Activin RIIB

Activin RIIB

Activin RIIB 詳細

Molecule Name
Activin receptor type-2B
分子の別称
ACVR2B,ACTRIIB,MGC116908
Drug Development Progress
治験薬の数6
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
EC:2.7.11.30,EC 2.7.11,Activin receptor type IIB,ACVR2B,Activin A Receptor Type 2B,Activin A Receptor, Type IIB,Activin Receptor Type-2B,EC 2.7.11.30,ActR-IIB,ACTRIIB,HTX4
バックグランド
Activin receptor type-2B (ACVR2B) is also known as ActR-IIB and MGC116908, ACVR2B is an activin type 2 receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Defects in ACVR2B are the cause of visceral heterotaxy autosomal type 4 (HTX4).

Activin RIIB 製品リスト

Species
  • Human(4)
  • Mouse(2)
  • Rabbit(1)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(2)
  • Fc Tag(1)
  • Fc Tag & Avi Tag(1)
Host
  • HEK293(7)
Conjugate
  • Unconjugated(4)
  • Biotin-labeled(3)
Grade
  • RUO(7)
Low Endotoxin
  • Yes(2)
  • No(5)
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BimagrumabLY-3985863; BYM-338Phase 2 ClinicalMorphosys Ag, Novartis Pharma Ag
Diabetes Mellitus, Type 2; Myositis, Inclusion Body; Obesity; Overweight; Pulmonary Disease, Chronic Obstructive; Sarcopenia
詳細
BIIB-110BIIB-110; BIIB110; ALG-801Phase 1 ClinicalAlivegen USA Inc
Muscular Atrophy, Spinal; Muscular Diseases
詳細
LAE-103LAE-103; LAE103Phase 1 ClinicalLaekna Therapeutics Shanghai Co Ltd
Muscular Diseases; Muscular Disorders, Atrophic; Obesity; Sarcopenia
詳細
SSS-67SSS67; SSS-67Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co Ltd
Obesity; Overweight
詳細
JMT-206JMT206; JMT-206Phase 1 ClinicalShanghai Jmt-Bio Inc
Body Weight; Obesity; Overweight; Sarcopenia
詳細
Tirzepatide/BimagrumabLY-900042Phase 1 ClinicalEli Lilly And Company
詳細
Customer Reviews